taking stock Archives - Telegraph247

Danaher is making good use of mergers and acquisitions once again. But we could have had enough

Danaher's days in the portfolio may be numbered. We were once again disappointed after Danaher's latest acquisition plan failed to…

Jim Cramer says not to worry about Novo Nordisk's lead over Club that has Eli Lilly in the obesity pill…

Danaher is finally turning the corner. CNBC's Jim Cramer sees it. Wall Street does it too. Life sciences stocks are…

Eli Lilly investors have received some very good news in recent months, with one notable exception regarding the stock's performance.…

Life sciences company Danaher certainly hasn't been an easy stock to buy this year. A wave of new companies going…

Eli Lilly has outperformed the S&P 500 for five straight years as Wall Street realized its huge opportunity in obesity…

The new trial data has cemented Club's lead position behind Eli Lilly in the highly competitive anti-obesity drug race. Eli…

Enthusiasm for Eli Lilly, the club's holding company, needs to be tempered, at least for now, as Wall Street grapples…

Shares of Abbott Laboratories rose on Friday after the Club holding company scored a surprise victory in a trial into…

GE Healthcare's quiet outperformance is becoming harder to ignore, and its new drug used in radiology to improve the diagnosis…